Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SB 211475

Known as: SB-211475 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
The aim of this study was to investigate the effect of SB 211475, a metabolite of carvedilol with weak alpha1-adrenoceptor… Expand
1998
1998
Reactive oxygen species have been demonstrated to play a critical role in post‐ischaemic tissue injury. The present experiment… Expand
Highly Cited
1994
Highly Cited
1994
The antioxidant effects of SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, were studied and compared with… Expand